DSpace Fukushima Medical University

福島県立医科大学学術成果リポジトリ = Fukushima Medical University Repository >
福島医学会 = The Fukushima Society of Medical Science >
Fukushima Journal of Medical Science >
Vol.67 (2021) >

このアイテムの引用には次の識別子を使用してください: http://ir.fmu.ac.jp/dspace/handle/123456789/1620

このアイテムのファイル:

ファイル 記述 サイズフォーマット
FksmJMedSci_67_p102.pdf241.59 kBAdobe PDFダウンロード
タイトル: Development of a self-administered questionnaire for the screening of cervical myelopathy. Part 2, investigation of its characteristics in surgical cases
著者: Kobayashi, Hiroshi
Otani, Koji
Handa, Junichi
Kato, Kinshi
Watanabe, Kazuyuki
Nikaido, Takuya
Yabuki, Shoji
Konno, Shin-Ichi
学内所属: 整形外科学講座
誌名/書名: Fukushima Journal of Medical Science
巻: 67
号: 3
開始ページ: 102
終了ページ: 106
発行日: 2021年
抄録: Background: Our previous report described the development of a self-administered questionnaire to screen patients for cervical myelopathy (SQC). For clinical application, the characteristics of the SQC should be verified. Methods: Participants comprised 129 patients (94 men, 35 women) with cervical myelopathy who underwent operative treatment. SQC score was calculated before surgery and patients were divided into a positive group (score ≥6) and negative group (score <6). Sex, age, pathologies of cervical myelopathy, Japanese Orthopaedic Association (JOA) score, 10-s grip-and-release test (10-s test), grip strength, number of levels decompressed, most cranial level of damage, and presence of diabetes mellitus (DM) were compared between groups. Results: The sensitivity was 89.9% with 116 positive cases and 13 negative cases (10.1%). JOA score was significantly higher and 10-s test and grip strength significantly better in the negative group than in the positive group. No significant differences in sex, age, pathologies of cervical myelopathy, number of spinal levels decompressed, most rostral level of damage, or presence of DM were seen between groups. Conclusions: Screening for cervical myelopathy using SQC had a high sensitivity of 89.9%. However, SQC should be used with caution because it may miss mild cervical myelopathy with low JOA scores.
出版者: The Fukushima Society of Medical Science
出版者(異表記): 福島医学会
本文の言語: eng
このページのURI: http://ir.fmu.ac.jp/dspace/handle/123456789/1620
本文URL: http://ir.fmu.ac.jp/dspace/bitstream/123456789/1620/1/FksmJMedSci_67_p102.pdf
ISSN: 0016-2590
2185-4610
DOI: 10.5387/fms.2021-03
PubMed番号: 34645735
関連ページ: https://doi.org/10.5387/fms.2021-03
権利情報: © 2021 The Fukushima Society of Medical Science. This article is licensed under a Creative Commons [Attribution-NonCommercial-ShareAlike 4.0 International] license.
権利情報: https://creativecommons.org/licenses/by-nc-sa/4.0/
出現コレクション:Vol.67 (2021)

このアイテムのファイル:

ファイル 記述 サイズフォーマット
FksmJMedSci_67_p102.pdf241.59 kBAdobe PDFダウンロード

このリポジトリに保管されているアイテムは、他に指定されている場合を除き、著作権により保護されています。

 

DSpace Software Copyright © 2002-2006 MIT and Hewlett-Packard